Molecular Biology Enzymes Kits and Reagents Market Report 2028

The molecular biology enzymes, kits, and reagents market is likely to be valued at US$ 15,715.48 million in 2022 and it is projected to reach US$ 41,104.71 million by 2028; it is expected to grow at a CAGR of 17.8% from 2022 to 2028.

Biological enzymes play a prominent role in encouraging chemical reactions in biological systems. Molecular biology enzymes are recommended for the preparation of laboratory samples. These reagents are also utilized during various processes such as polymerase chain reaction (PCR), DNA sequencing, and cell analysis. The growth of the market is attributed to a few key driving factors such as healthy funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases. However, the dearth of skilled professionals hinders the market growth.

The molecular biology enzymes, kits, and reagents market is witnessing substantial growth amid COVID-19 pandemic. The majority of the healthcare research organizations, market players, and academic centers are actively engaged in the research and development activities to develop new vaccines and therapeutic platforms for novel coronavirus that causes COVID-19. This extensive rise in research and development activities is expected to boost the demand for molecular biology kits and reagents, which, in turn, would drive the growth of the molecular biology enzymes, kits, and reagents market in coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Molecular Biology Enzymes, Kits, and Reagents Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights
Healthy Funding for Genomics Drives Market Growth

Genome sequencing was restricted to the research facilities, a few years back. However, it has now became one of the common techniques in clinical practices. Over the next few years, the healthcare sector is expected to generate genomic data of over 60 million patients. The growing implementation of genomic sequencing into healthcare systems is supported by substantial government investments, totaling over US$ 4 billion in at least 14 countries. The UK has announced the world’s largest genome project as part of 200 million public–private collaboration between charitable organizations and pharmaceutical companies. The country has already developed the world’s largest genome database through the 100,000 Genomes Project. Led by Innovate UK, a part of UK Research and Innovation, the project was initiated to support researchers and industries through funds to combine data and real-world evidence obtained from UK health services as well as to create new products and services for more efficient and early disease diagnosis.

In November 2018, Stilla Technologies, France, announced the completion of a Series A financing round, gathering US$ 18.3 million (EUR 16 million) in funds; the round was led by Illumina Ventures. The company plans to use these funds to commercialization of its Naica digital PCR system and development of clinical applications. Further, in June 2020, Base Genomics, an epigenetics company based in Oxford, England, closed a seed funding round of US$ 11 million (GBP 9 million). In August 2018, Nebula Genomics, a company based in Boston, Massachusetts, along with 10 leading venture capital firms, raised US$ 4.3 million in seed funding. as a part of partnership with Veritas Genetics, a genome sequencing company. The company aims to use these funds to create a trustworthy, secure, and decentralized marketplace for genomic data. In March 2018, SynbiCITE (UK) received grants worth ~US$ 17.6 million (GBP 13 million) and private investments worth US$ 318.5 million (GBP 234 million). The company is made for increasing synbio applications in the UK. The SynbiCITE has supported the synbio at national level for the increase of gene synthesis applications.

In April 2020, MedGenome, a genetic diagnostics, research, and data company headquartered in Bengaluru, India, raised US$ 55 million (~INR 419 crore) in a new round of funding, led by LeapFrog Investments, a global impact investment firm. MedGenome also claims to have built the largest database of South Asian genetic variants in genetic diagnostics in India and research partnerships. It has conducted over 200,000 genomic tests to date by obtaining samples from more than 550 hospitals and 6,000 clinicians across India.

Such continuous funding by the manufacturers and governments in the field of genomics is supporting the molecular biology enzymes, kits, and reagents market growth.

Product-Based Insights

Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other. The kits & reagent segment held a larger market share in 2020, and the same segment is estimated to register a higher CAGR during the forecast period.

Application-Based Insights

The molecular biology enzymes, kits, and reagents market, based on application, is segmented into epigenetics, sequencing, synthetic biology, polymerase chain reaction, and other. In 2020, the sequencing segment held the largest market share. However, the polymerase chain reaction segment is estimated to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the molecular biology enzymes, kits, and reagents market is segmented into biotechnological and pharmaceutical companies, hospitals and diagnostic centers, and academic and research institutes. The biotechnological and pharmaceutical companies segment held the largest share of the market in 2020, and the same segment is estimated to register the highest CAGR during the forecast period.

The molecular biology enzymes, kits, and reagents market players are adopting the product launch and expansion strategies to meet changing customer demands worldwide, which allow them to maintain their brand name globally.

Molecular Biology Enzymes Kits and Reagents Market Report Scope

Molecular Biology Enzymes, Kits, and Reagents Market Regional Insights

The regional trends and factors influencing the Molecular Biology Enzymes, Kits, and Reagents Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Molecular Biology Enzymes, Kits, and Reagents Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Molecular Biology Enzymes, Kits, and Reagents Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Molecular Biology Enzymes, Kits, and Reagents Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Molecular Biology Enzymes, Kits, and Reagents Market are:

1. THERMO FISHER SCIENTIFIC INC
2. Illumina, Inc.
3. Qiagen
4. Agilent Technologies, Inc.
5. F. HOFFMANN-LA ROCHE LTD

Disclaimer: The companies listed above are not ranked in any particular order.

Molecular Biology Enzymes, Kits, and Reagents Market – by Product

• Enzymes
  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents
  • Lyophilisable and air dryable
  • NGS
  • PCR
    • Real-time PCR/ quantitative real-time PCR (qPCR)
    • Reverse transcriptase PCR (RT-PCR)
    • Multiplex PCR
    • Others
• cDNA synthesis
• isothermal amplification
• DNA extraction
• others

Molecular Biology Enzymes, Kits, and Reagents Market – by Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

Molecular Biology Enzymes, Kits, and Reagents Market – by End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

Molecular Biology Enzymes, Kits, and Reagents Market – by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South America and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• THERMO FISHER SCIENTIFIC INC
• Illumina, Inc.
• Qiagen
• Agilent Technologies, Inc.
• F. HOFFMANN-LA ROCHE LTD
• Merck KGAA
• Jena Bioscience GmbH
• Bioline Technologies
• Promega Corporation
• Rockland Immunochemicals